期刊文献+

外周血CD44v6在急性白血病中的表达及临床意义 被引量:1

Expressionof CD44v6 in acute leukemiand itimplication to clinical outcome
原文传递
导出
摘要 目的探讨外周血CD44v6在急性白血病(AL)中的表达及与预后的关系。方法采用酶联免疫吸附试验(ELISA)检测60例AL患者初治时(初治时组)、经联合化疗达缓解47例患者(缓解组)、其中20例又复发患者(复发组)及45例良性血液病患者(正常对照组)的外周血CD44v6浓度,分析其不同表达水平的差异。结果初治时组CD44v6水平(179.34±39.41)μg/L、复发组(190.61±28.05)μg/L、缓解组(106.72±26.38)μg/L和正常对照组(98.31±21.78)μg/L,组间比较差异有统计学意义(F=56.303,P〈0.01),其中初治时组和复发组又高于缓解组和正常对照组,差异有统计学意义(P均〈0.05)。60例AL患者初治时白细胞水平与CD44v6水平呈正相关(r=0.826,P〈0.01),与疾病危险分层、有无髓外浸润亦呈正相关(r值分别为0.485和0.512,P均〈0.01)。结论CD44v6升高与AL发病和病情进展有关,对其动态监测有利于判断病情和预测复发。 Objective To investigate the significance of CIM4v6 expression in acute leukemi(AL) and it'relation with the prognosiof AL. MethodSixty AL patientwere treated by' enzyme linked immunosorbenassay(ELISA) ainitial treatmengroup. Fourty-seven casewere remission aremission group, and 20 casewith no-remission group. Meanwhile ,45 healthy people were served athe control group. The level of CD44v6 wameasured by ELISA. ResultThe serum CIM4v6 in initial treatmenpatients,remission group, no-remission group and control group were ( 179. 34 ± 39.41 ) μg/L, ( 190. 61 ± 28.05 ) μg/L, ( 106. 72 ±26. 38)μg/L and (98. 31 ±21.78 ) μg/L respectively, and the difference wasignificant( F = 56. 303, P 〈0. 01 ) ,and the CD44v6 of initial treatmengroup and remission group were highethan thaof no-remission group and control group (P 〈 0. 05 ). The leukocyte levelwapositive related to CD44v6 levelin 60 patient(=0. 826 ,P 〈0.01 ) ,and iwaalso related to disease stage, extramedullary infiltration( ( = 0. 485,0. 512 ;P 〈 0. 01 ). Conclusion The level of CD44v6 iclosely related with the occurrence and developmenof acute leukemia. The assay of CD44v6 in serum of AL patientihelpful in diagnosing and predicting the risk of metastasiand prognosiin AL
出处 《中国综合临床》 2015年第2期146-148,共3页 Clinical Medicine of China
关键词 急性白血病 CD44V6 缓解率 复发 预后 Acute leukemia CD44v6 Complete remission rate Relapse Prognosis
  • 相关文献

参考文献6

二级参考文献43

  • 1宋懿懿,顾爱琴,韩宝惠.p21、p53和c-erbB-2在非小细胞肺癌组织中的表达及临床意义[J].上海交通大学学报(医学版),2011,31(3):295-298. 被引量:6
  • 2Kazou T. Expression of CD44 variant exons in colorectal cancer and its relationship metastasis [J]. Jpn J Cancer Res, 1995, 86:292.
  • 3Speiser P, Kridelka F, Tempfer C, et al. CD44v6 expression is an independment prognostic factor in node-negtive FIGO stage Ⅰ b cervical carcinoma[J]. Int J Gynecol Cancer,1999, 2:160.
  • 4Ayhan A, Baykal C, AL A, et al. Altered CD44 variant 6 expression in FIGO stage Ⅰ b cervical carcinoma[J]. Gyncol Oncol, 2001,83:569- 574.
  • 5Kainz C, Khlberger D, Sliutz G, et al. Splice variants of CD44 in human cervical cancer stage Ⅰ b to Ⅱ b[J]. Gyncol Oncol, 1995,57:383- 387.
  • 6Droll A, Nicholas HB, Facukh SM, et al. Adhesive interactions between alternatively spliced CD44 isoforms[J]. J Bio Chem, 1995, 270:11567.
  • 7Alberg AJ,Brock MV,Samet JM.Epidemiology of lung canceT:looking to the future[J].J Clin Oncol,2005,23 ( 14 ):3175-3785.
  • 8Akita K,lnaguki H,Sato S,et al.pi85 ( HER-2/neu ) and p21(CIP1/WAF1 ) expression in primary tumors and lymph nodemetastases in non-small cell lung cancer[J].Jpn J Cancer Res,2002,93(9):1007-1011.
  • 9Vallbdhmer D,Brabender J,Yang DY,et al.Sex differences in thepredictive power of the molecular prognostic factor HER2/neu inpatients with non-small-cell lung cancer[J].Clin Lung Cancer,2006,7(5):332-337.
  • 10Laack E,Scheffler A,Burkholder I,et al.Pretreatment vascularendothelial growth factor ( VEGF) and matrix metalloproteinase-9(MMP-9) serum levels in patients with metastatic non-small celllung cancer( NSCLC)[J].Lung Cancer,2005,50( 1 ):51-58.

共引文献52

同被引文献24

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部